首页>
外国专利>
METHODS OF TREATING ANTI-NMDAR-ASSOCIATED NEUROPSYCHIATRIC DISORDERS
METHODS OF TREATING ANTI-NMDAR-ASSOCIATED NEUROPSYCHIATRIC DISORDERS
展开▼
机译:治疗抗NMDAR相关的神经性精神疾病的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present disclosure is directed to methods for treating a neuropsychiatric disorder associated with expression of autoantibodies to ionotropic glutamate receptor, NMD A 2A (GiuN2A), expression of anti-double-stranded (ds) DNA antibodies that cross react with one or more subunits of the NMD A receptor, or a mutation in the ionotropic glutamate receptor NMD A type subunit 2A (GRIN2A) gene. The methods involve administering a memantine, or a pharmaceutically acceptable salt thereof, to a subject suffering from a neuropsychiatric disorder associated with expression of GluN2A or a mutation in the GRIN2A gene.
展开▼
机译:本公开内容涉及用于治疗与精神离子性谷氨酸受体NMD A 2A(GiuN2A)的自身抗体的表达,与双链氨基酸的一个或多个亚基交叉反应的抗双链(ds)DNA抗体的表达相关的神经精神疾病的方法。 NMD A受体,或离子型谷氨酸受体NMD A 2A亚型(GRIN2A)基因的突变。该方法包括向患有与GluN2A的表达或GRIN2A基因的突变相关的神经精神疾病的受试者施用美金刚或其药学上可接受的盐。
展开▼